NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in RevenuesGlobeNewsWire • 11/11/25
NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered LivesGlobeNewsWire • 06/17/25
NeurAxis Stock Gains Following Strong Q1 Earnings and FDA MilestonesZacks Investment Research • 05/15/25
NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in RevenuesGlobeNewsWire • 05/12/25
NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025GlobeNewsWire • 05/05/25
NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in RevenuesGlobeNewsWire • 03/20/25
NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025GlobeNewsWire • 03/12/25
UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple StatesGlobeNewsWire • 01/21/25
NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple StatesGlobeNewsWire • 01/21/25
NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025GlobeNewsWire • 01/06/25
NeurAxis Stock Surges After Strong Q3 Earnings and Expanded CoverageZacks Investment Research • 11/15/24
NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in RevenuesGlobeNewsWire • 11/12/24
NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field StimulationGlobeNewsWire • 10/22/24
NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024GlobeNewsWire • 09/19/24
NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024GlobeNewsWire • 08/27/24